We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current PARNF market cap is 9.87M. The company's latest EPS is AUD -0.0477 and P/E is -1.68.
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 26.69M | 28.99M | 30M | 34.34M | 35.43M |
Operating Income | 3.41M | 2.98M | 3.15M | 3.6M | 2.5M |
Net Income | 130k | -7.18M | -15.06M | -1.42M | -5.74M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 33.48M | 39.04M | 40.58M | 40.11M | 41.78M |
Total Liabilities | 52.01M | 65.26M | 72.43M | 74.9M | 89.77M |
Total Equity | -18.53M | -26.23M | -31.86M | -34.79M | -48M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -1.62M | 2.27M | -4.76M | 5.45M | 2.36M |
Investing | -2.76M | -2.74M | -3.35M | -4.17M | -6.62M |
Financing | 6.16M | 993k | 9.43M | 67k | 2M |
Market Cap | 9.87M |
Price to Earnings Ratio | -1.68 |
Price to Sales Ratio | 0.27 |
Price to Cash Ratio | 5.26 |
Price to Book Ratio | -0.2 |
Dividend Yield | - |
Shares Outstanding | 120.38M |
Average Volume (1 week) | 1.03k |
Average Volume (1 Month) | 34.39k |
52 Week Change | 8,199,900.00% |
52 Week High | 0.35 |
52 Week Low | 0.000001 |
Spread (Intraday) | 0 (0%) |
Company Name | Parnell Pharmaceuticals Holdings Ltd (CE) |
Address |
unit 4 century estate sydney, new south wales 2015 |
Website | https://www.parnell.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions